Industry / Pharmaceuticals: Other
Latest filings
F-6
ESALF
Eisai
20 Jan 23
Registration for ADRs (foreign)
3:22pm
F-6EF
ESALF
Eisai
9 Jan 23
Automatic registration for ADRs (foreign)
9:45am
DFAN14A
INDV
Indivior
20 Dec 22
Additional proxy materials by non-management
2:41pm
DFAN14A
INDV
Indivior
7 Dec 22
Additional proxy materials by non-management
10:27am
RW
Mallinckrodt
6 Dec 22
Registration withdrawal request
5:15pm
10-Q
2022 Q3
CDXQ
Nhale
16 Nov 22
Quarterly report
10:15am
NT 10-Q
CDXQ
Nhale
14 Nov 22
Notice of late quarterly filing
4:49pm
1-U
GSAC
Gelstat
7 Oct 22
Current report (pursuant to Regulation A)
5:12pm
1-SA
GSAC
Gelstat
3 Oct 22
Semiannual report
5:13pm
10-Q
2022 Q2
CDXQ
Nhale
8 Sep 22
Quarterly report
9:46pm
Transcripts
ALPMF
Earnings call transcript
2022 Q3
31 Oct 22
SGIOF
Earnings call transcript
2022 Q1
2 Aug 22
EMHTF
Earnings call transcript
2021 Q2
31 Aug 21
EMHTF
Earnings call transcript
2020 Q4
3 May 21
FOMX
Earnings call transcript
2020 Q3
7 Nov 20
MYOK
Earnings call transcript
2020 Q2
5 Aug 20
MYOK
Earnings call transcript
2019 Q4
27 Feb 20
MYOK
Earnings call transcript
2019 Q2
7 Aug 19
MYOK
Earnings call transcript
2019 Q1
9 May 19
MYOK
Earnings call transcript
2018 Q4
4 Mar 19
Patents
Utility
Compositions and methods for treating cancer
24 Jan 23
Utility
Compound Having Lysophosphatidic Acid Receptor Agonist Activity and Pharmaceutical Use Thereof
OPHLY
19 Jan 23
Utility
Use of Valproic Acid for Reducing Post-operative Scarring Following a Glaucoma Surgery
SNPHY
19 Jan 23
Utility
Compositions and methods for treating cancer
17 Jan 23
Utility
Compositions and methods for treating cancer
27 Dec 22
Utility
Dispensing Device And Assembly For Packaging And Dispensing Product
SNPHY
8 Dec 22
Utility
Medicament Comprising Combination of Sepetaprost and Rho-associated Coiled-coil Containing Protein Kinase Inhibitor
SNPHY
8 Dec 22
Utility
EP2 Antagonist
OPHLY
8 Dec 22
Utility
BRK inhibitory compound
OPHLY
29 Nov 22
Utility
a Pharmaceutical Composition for Treating Hematological Cancer
OPHLY
24 Nov 22